The Life Sciences BPO market is estimated to be valued at US$ 222.9 Bn in 2022 and is expected to exhibit a CAGR of 14.7% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.Market Overview:The Life Sciences BPO market offers business process outsourcing services to pharmaceutical, biotechnology, and medical device companies. These...
The life sciences BPO market is estimated to be valued at US$ 385.8 Bn in 2023 and is expected to exhibit a CAGR of 14% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:The life sciences BPO market encompasses outsourcing services for various industry domains like pharmaceutical, biotechnology, medical devices, and...
The Life Sciences BPO Market experienced significant impacts due to the Covid-19 pandemic. With the outbreak causing disruptions across the global healthcare landscape, life sciences companies faced challenges in managing their operations efficiently. However, the pandemic also presented opportunities for the industry to adapt and innovate. As healthcare providers and pharmaceutical companies...
Outsourcing clinical trials is a major driver of the life sciences BPO market, with clinical trials being the largest segment in terms of revenue. Outsourcing certain aspects of clinical trials can help pharmaceutical and biotech companies reduce costs, increase efficiency, and accelerate drug development timelines.
Life Sciences BPO Market providers offer specialized expertise in areas...